Pages

Tuesday, July 20, 2021

Fw: Ref.: (LML) Neglect of persons who experienced HD

 


Leprosy Mailing List – July 20,  2021

 

Ref.:  (LML) Neglect of persons who experienced HD

 

From:  Joel Almeida, London and Mumbai

 

 

Dear Pieter and colleagues,

 

Recent reports highlight the neglect of persons who experienced HD (leprosy).

 

Instead of self-settled colonies becoming havens of good health care, and adequate services, they tend to be dumping grounds where excluded human beings are treated by too many as non-persons (using the memorable description of Advocate Pankaj Sinha. He had previously brought a Public Interest Litigation before the Supreme Court of India). These persons are excluded even from registers of persons thought to be receiving competent care. They are too often invisible, even to their well-wishers.

 

Exclusion of persons who experienced HD, from registers, was disregarded by the bacilli, who kept on producing hundreds of thousands of new cases per year. But that is not the end of the story. Self-settled colonies are prime candidates for exemplary projects where respect for every human being is demonstrated by competent care and adequate services. Ending the anti-microbial and wider neglect of persons in "HD colonies" can demonstrate the impacts of adequate services. We could stop transmission, reduce new disabilities, and start replacing exclusion with inclusion. Such exemplary projects would counter misplaced scepticism, and allow success to spread everywhere.

 

Excluded people too often have been unable to marry outside the circle of excluded persons. They also tend to be pushed into poverty or extreme poverty. Their predicament is accompanied by some elevation in genetic risk factors and other risk factors for HD. Therefore rapid success in self-settled "HD colonies" would be powerful. Not only would it benefit the neglected and excluded people but also it would help demonstrate to governments and other sources of finance that success is possible everywhere.

 

The exemplary SHF (Sasakawa Health Foundation) /WHO project in FSM (Federated States of Micronesia) offers important clues about how to achieve rapid success in hyperendemic "hot spots". Every self-settled "HD colony" could be freed rapidly from HD and its worst consequences, when we implement a few key actions:

 

1) Periodic skin camps for all conditions with expert clinicians, and smear microscopy, so that LL cases can be diagnosed even while they display only subtle signs of LL HD.

 

2) Prolonged anti-microbial protection for LL patients, so that reinfection is stopped and sources of concentrated viable bacilli become unavailable. No child need be exposed to concentrated viable bacilli.

 

3) Mass multi-drug administration (MDA) at intervals of less than a year. This probably needs to be repeated relentlessly until no child is found with HD during a period of several years. The SHF/WHO project demonstrated a 92% reduction in risk of HD among those who received ROM (rifampicin + ofloxacin + minocycline) compared to those who did not. The use of multi-drugs delays selection of drug-resistant bacilli. Otherwise drug resistance could put HD control out of our reach for decades.

 

4) A wide social movement to empower excluded people by offering competent care (including protection against reinfection for LL patients), social welfare measures, rehabilitation, education, upskilling, training, creating jobs, opportunities to mingle with people who have never experienced HD, chances to participate in mainstream life, reliable information to the public and legislators, and legal aid to help enforce rights.

 

The SHF/WHO FSM project also demonstrated an 84% reduction of new cases/year within a short span of only 2 years. It seems wise to learn from what really works, so that our efforts can become more surely and rapidly effective.

 

Fortunately, the world has some noble-minded philanthropic organisations who are capable of financing exemplary projects in self-settled "HD colonies". There is no reason for delay. These colonies tend to be among the hottest of hyperendemic "hot spots". They also tend to have an elevated incidence rate of extremely painful ENL episodes, owing to enforced anti-microbial neglect of LL patients after 12 months of MDT. All this will change when we remedy the anti-microbial and wider neglect of people who experienced HD. Such remedies can transform self-settled "HD colonies" into powerful examples of success with near zero new cases, near zero new disability, near zero ENL, near zero hunger and near zero neglect. 

 

Joel Almeida

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/9bea13de-abf9-4bee-b974-15395c19d5dfn%40googlegroups.com.

Wednesday, July 14, 2021

Fw: Ref.: (LML) Infolep monthly overview of new publications on leprosy - July '21


 

 

 

 

Leprosy Mailing List – July 14,  2021

 

Ref.:  (LML) Infolep monthly overview of new publications on leprosy - July '21

 

 

From:  Anniek Akerboom, Amsterdam, the Netherlands

 



Dear colleagues, 

The Infolep monthly overview has a new look and google translate feature! You can now translate this newsletter by clicking on the top right button "Translate email". The newsletter will then open in your browser, where you can click on the drop-down menu "Translate" on the top right of your screen and choose your preferred language. Please contact us if you have any questions or feedback.

The Global Partnership for Zero Leprosy (GPZL) launched a video about Ghana's Zero Leprosy Country Review. In November 2020, GPZL worked with the Ghanaian ministry of health to review the National Leprosy Programme and develop a roadmap to zero leprosy for Ghana. Watch the video to see what the Ghana team learned and how they are applying these insights to reach the goal of zero leprosy by 2030. Read more about the Country Model components and how GPZL supports countries here. 

Below you will find the list with new publications on leprosy and interesting events, including online courses. Feel free to contact me to receive full-text versions if these cannot be found through the Infolep portal. Also, I would be happy to assist you with literature searches on Infolep.

Warm regards,

Anniek Akerboom

Infolep Coordinator
www.leprosy-information.org
a.akerboom@infolep.org
 

 



 



Highlighted

 



Task Force on definitions, criteria and indicators for interruption of transmission and elimination of leprosy
World Health Organization. 2021.
 

Blood RNA signature RISK4LEP predicts leprosy years before clinical onset

Tió-Coma M, Kiełbasa SM, van den Eeden SJ, et al. EBioMedicine. Elsevier BV. 2021.

 

CBM's Community Mental Health Good Practice Guides
CBM. 2021.
 

 



 



Leprosy & COVID-19

 



An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres
de Barros B, Lambert SM, Negera E, et al. Oxford University Press (OUP). Transactions of The Royal Society of Tropical Medicine and Hygiene. 2021.
 

Impact of the COVID-19 pandemic on the diagnosis of new leprosy cases in Northeastern Brazil, 2020.
Matos T, Nascimento V, Carmo R, et al. International journal of dermatology. 2021.
 

Disproportionate impact of the coronavirus disease (COVID19) pandemic on persons affected by leprosy and their family members: root causes, consequences and the way to recovery
Cruz A. United Nations. 2021.
 

El grupo de trabajo 1 AGCL evalúa los desafíos y la ruta a seguir para la lepra durante el COVID-19
Cavaliero A, Quao BO. Revista de leprología. 2021; 33 (1) : 61-64.
 

 



 



New publications

Towards a cross-neglected tropical disease perception study toolkit: a prototype toolkit developed in the field of leprosy
Anna T van 't Noordende, Wim H van Brakel. Leprosy Review. 2021.
 

Undernutrition, food insecurity, and leprosy in North Gondar Zone, Ethiopia: A case-control study to identify infection risk factors associated with poverty.
Anantharam P, Emerson L, Bilcha K, et al. PLoS neglected tropical diseases. 2021; 15 (6) : e0009456.
 

Patterns and determinants of treatment completion and default among newly diagnosed multibacillary leprosy patients: A retrospective cohort study
Pepito VCF, Amit AML, Samontina RED, et al. Heliyon. Elsevier BV. 2021; 7 (6) : e07279.
 

Improving The Ability of Self-Caring of Leprosy Survivor Through Family Psychoeducation
Handaris MA, Rosmaharani S, Rodiyah R. Media Keperawatan Indonesia. LPPM Universitas Muhammadiyah Semarang. 2021; 4 (2) : 133.
 

Autophagy as a Target for Drug Development Of Skin Infection Caused by Mycobacteria.
Bittencourt T, Prata R, Silva B, et al. Frontiers in immunology. 2021.
 

The nitrosamine contamination of drugs, part 3: Quantification of 4-Methyl-1-nitrosopiperazine in rifampicin capsules by LC-MS/HRMS.
Wohlfart J, Scherf-Clavel O, Kinzig M, et al. Journal of pharmaceutical and biomedical analysis. 2021.
 

Leprosy-Related Chronic Arthritis with an Abundance of Mycobacterium Leprae in the Synovial Fluid: A Rare Case
Gunawan H, Wulansari Y, Achdiat PA, et al. International Medical Case Reports Journal. Informa UK Limited. 2021.
 

Leprosy in medieval Denmark: Exploring life histories through a multi-tissue and multi-isotopic approach.
Brozou A, Fuller B, Grimes V, et al. American journal of physical anthropology. 2021.
 

Leprosy and the Colonial Gaze: Comparing the Dutch West and East Indies, 1750-1950.
Snelders S, van Bergen L, Huisman F. Social history of medicine : the journal of the Society for the Social History of Medicine. 2021; 34 (2) : 611-631.

 

Psychosocial burden of neglected tropical diseases in eastern Colombia: an explorative qualitative study in persons affected by leprosy, cutaneous leishmaniasis and Chagas disease
van Wijk R, van Selm L, Barbosa MC, et al. Cambridge University Press (CUP). Global Mental Health. 2021. 
 

The impact of podoconiosis, lymphatic filariasis, and leprosy on disability and mental well-being: A systematic review.
Ali O, Mengiste A, Semrau M, et al. PLoS neglected tropical diseases. 2021; 15 (7) : e0009492.
 

Active search strategies, clinicoimmunobiological determinants and training for implementation research confirm hidden endemic leprosy in inner São Paulo, Brazil.
Filho F, Silva C, Voltan G, et al. PLoS neglected tropical diseases. 2021; 15 (6) : e0009495.
 

Epidemiological, neurofunctional profile and prevalence of factors associated with the occurrence of physical disabilities due to leprosy in a reference center in Northeast Brasil: a sectional study.
Matos T, de Moura J, Fernandes T, et al. Revista da Associacao Medica Brasileira (1992). 2021.
 

Knowledge, attitude, and health seeking behavior on leprosy among urban adults in Kancheepuram district of Tamil Nadu: A Community-based cross-sectional study
Gopalakrishnan S, Grace G, Sujitha P, et al. Journal of Family Medicine and Primary Care. Medknow. 2021; 10 (5) : 1895. 
 

Factors Influencing Leprosy Incidence: A Comprehensive Analysis of Observations in Wenshan of China, Nepal, and Other Global Epidemic Areas.
Li Y, Shakya S, Long H, et al. Frontiers in public health. 2021. 
 

Predictive nomogram for leprosy using genetic and epidemiological risk factors in Southwestern China: Case-control and prospective analyses.
Long S, Sun J, Wang L, et al. EBioMedicine. 2021.
 

Relevância do grau de incapacidade física como preditor do diagnóstico tardio em hanseníase: Uma revisão de escopo
Alves GMG, Almeida AGCDS, Licetti MM, et al. Research, Society and Development. Research, Society and Development. 2021; 10 (6) : e5410615399. 



Events

 




 



 



Events

 



NNN/COR-NTD Webinar Rising to the challenge: Overcoming challenges to monitoring and evaluating COVID-19 mitigation strategies
15 Jul 2021 | Virtual
 

Online courses from the London School of Hygiene & Tropical Medicine:

NNN Conference 2021
7-9 Sep 2021 | Virtual
 

Webinar recording: The impact of the Covid-19 pandemic on persons affected by leprosy
At the UN's COSP14 (Disability Rights) meeting 2021, The Leprosy Mission and Disabled Peoples' International hosted a side event looking at the impact of the Covid-19 pandemic on the fight to defeat leprosy and what it has meant for persons affected by leprosy.
 

Webdocumentary: Principles and Guidelines for the elimination of discrimination against persons affected by leprosy and their family members - From the draft to law in action
Alice Cruz, UN Special Rapporteur
 

 

 



 



Links


 

 



Info Hansen - A innovative hub for knowledge sharing about Hansen's Disease
 

ALLF - Official website of the Association des Léprologues de Langue Française
 

LML - Leprosy Mailing List - a free moderated email list that allows all persons interested in leprosy to share ideas, information, experiences and questions
 

InfoNTD - Information on cross-cutting issues in Neglected Tropical Diseases (NTDs)

 

ILEP newsletter archive

GPZL newsletter archive

WHO Goodwill Ambassador's Leprosy Bulletin

Leprosy Review

Leprosy Review Repository (1928-2001)

Fontilles Revista de Leprología

Indian Journal of Leprosy

Hansenologia Internationalis

 

 

GDPR & the Infolep newsletter

 
New EU data protection regulations came into force on 25 May 2018. We have been reviewing our practices with regards to the GDPR, including our privacy statement and mailing list.

Infolep sends out monthly e-mails with an overview of recent publications on leprosy and related issues. The purpose of this activity is to keep subscribers up to date.

Infolep will only process the data we have (names, email addresses) for the purpose of sending you the newsletter. We take your security seriously and will never share your contact details with anyone else.

You can update your preferences or unsubscribe from this list at any time.

 

 

LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

--
You received this message because you are subscribed to a topic in the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this topic, visit https://groups.google.com/d/topic/leprosymailinglist/kRVrgc6uPY4/unsubscribe.
To unsubscribe from this group and all its topics, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/eb72b648-d1ae-4e78-a556-c8fe16bb27d6n%40googlegroups.com.

Thursday, July 8, 2021

Fw: Ref.: (LML) Assessment checklist for Leprosy (Hansen's Disease) referral facilities

 


Leprosy Mailing List – July 8 ,  2021

 

Ref.:  (LML) Assessment checklist for Leprosy (Hansen's Disease) referral facilities

 

From:  Alphonsus Chukwuka, Enugu, Nigeria

 

Dear colleagues,

 

Greetings from Nigeria!


We are trying to assess the functionality of Leprosy (Hansen's Disease) referral facilities in some states in Southern Nigeria with a view to improving some aspects of care especially in the management of complicated HD.

-       Does anyone have any experience in that?

-       What were your objectives?

-       What tools (checklist/methods) did you use?

-       How did you go about it?


Regards,

 

Chukwuka Alphonsus

 

Medical Adviser

DAHW - German Leprosy and TB Relief Association

56 Nza Street / Independence Layout / Enugu

Enugu State, Nigeria

Email office: dahw.medical@dahw.org   

Email personal:  chukwuka.alphonsus@dahw.org 

Phone office: +234 706 749 0052 and +234 808 055 7461

Phone Private: +234 703 076 5227

Website: www.glra.org.ng

*Please reconsider printing out this email, because we want to preserve nature*"


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/208896c4-60e3-4d27-9fa2-eb3cf746f935n%40googlegroups.com.

Friday, July 2, 2021

Fw: Ref.: (LML) Human Rights Council Report SR Leprosy



Leprosy Mailing List – July 2,  2021

 

Ref.:  (LML) Human Rights Council Report SR Leprosy

 

From:  Alice Cruz, Quinto, Ecuador

 

 

Dear friends and partners,


Kindly find attached my thematic report to the Human Rights Council "Disproportionate impact of the coronavirus disease (COVID-19) pandemic on persons affected by leprosy and their family members: root causes, consequences and the way to recovery" in English, French and Spanish, and a fact sheet produced by my wonderful team with its key points.


I am also happy to inform you that I will be presenting my thematic report on the 1st July. I take the opportunity to convey my gratitude to all the organizations and people who contributed to my report, your support was, as always, precious and decisive!


Warmly,


Alice



 

PORTUGUÊS


Queridxs amigxs e parceirxs,


Por favor encontrem em anexo o meu relatório temático para o Conselho de Direitos Humanos "O impacto desproporcionado da COVID-19 nas pessoas afectadas pela hanseníase e membros das suas famílias: causas, consequências e o caminho para a recuperação" em Inglês, Francês e Espanhol e uma ficha informativa produzida pela minha equipa maravilhosa com os seus principais pontos.


Também me compraz comunicar-lhes que apresentarei o meu relatório temático no próximo dia 1 de Julho. Aproveito para transmitir o meu profundo agradecimento a todas as organizações e pessoas que contribuíram para o meu relatório, o vosso apoio foi, como sempre, precioso e decisivo!


Cordialmente,


Alice


 

ESPAÑOL


Estimados amigxs y compañerxs,


Se adjunta amablemente mi informe temático al Consejo de Derechos Humanos "Impacto desproporcionado de la pandemia de la enfermedad del coronavirus (COVID-19) en las personas afectadas por la lepra y sus familiares: causas fundamentales, consecuencias y el camino hacia la recuperación" en inglés, francés y español y una hoja informativa producida por mi equipo maravilloso con sus puntos clave.


También me complace informarles que presentaré mi informe temático el 1 de julio. Aprovecho para transmitir mi agradecimiento a todas las organizaciones y personas que contribuyeron a mi informe, ¡su apoyo fue, como siempre, precioso y decisivo!


Saludos Cordiales,



Alice

 

FRANÇAIS


Chers amis et partenaires,


Veuillez trouver ci-joint mon rapport thématique au Conseil des droits de l'homme « Impact disproportionné de la pandémie de la maladie à coronavirus (COVID-19) sur les personnes touchées par la lèpre et les membres de leur famille : causes profondes, conséquences et chemin vers le rétablissement » en anglais, français et espagnol, et une fiche d'information produit par ma merveilleuse équipe avec ses points clés.


J'ai également le plaisir de vous informer que je présenterai mon rapport thématique le 1er juillet. J'en profite pour exprimer ma gratitude à toutes les organisations et personnes qui ont contribué à mon rapport, votre soutien a été, comme toujours, précieux et décisif!


Cordialement,


Alice

 


LML - S Deepak, B Naafs, S Noto and P Schreuder

LML blog link: http://leprosymailinglist.blogspot.it/

Contact: Dr Pieter Schreuder << editorlml@gmail.com

 

 

--
You received this message because you are subscribed to the Google Groups "Leprosy Mailing List" group.
To unsubscribe from this group and stop receiving emails from it, send an email to leprosymailinglist+unsubscribe@googlegroups.com.
To view this discussion on the web, visit https://groups.google.com/d/msgid/leprosymailinglist/1d15088e-f5ac-4159-90eb-dd5e37b902ccn%40googlegroups.com.